leadf
logo-loader
viewRyah Medtech Inc

RYAH Medtech data finds women make up 45% of medical cannabis users, start treatment later in life

Compared with men, women are more likely to use medical cannabis to treat anxiety, depression, chronic pain, and fibromyalgia

Woman holding cannabis leaf
The report featured survey feedback from 28,211 women

RYAH Medtech Inc has released an analytics report that takes a closer look at how women use medical cannabis.

The report, which featured survey feedback from 28,211 women, found that the average female patient starts treating with medical cannabis slightly later in life than the average man and uses a variety of cannabis profiles to treat mental health conditions.

CEO Greg Wagner believes women have been lumped into a single category at times by the industry, despite making up nearly half of medical cannabis users.

READ: RYAH Medtech forges research partnership with top Pharma and Oncology player

"The female patient demographic has not received enough industry attention or study up to this point,” Wagner said in a statement.  “Making up more than 45% of the patient pool, it’s our responsibility to better understand what this demographic looks like, which medical issues they are seeking treatment for and what treatments are providing successful outcomes.”

Specifically, the report found that compared with men, women are more likely to use medical cannabis to treat anxiety, depression, chronic pain, and fibromyalgia. Female patient utilize CBD-rich, THC-rich and balanced strains, and seem to have no preference between indica and sativa. 

The data helped confirm a 2016 California study that said women tend to begin using medical marijuana later in life than men, typically after 30 years of age.

The statistics used in the report were compiled from RYAH’s proprietary data pool, a HIPAA-compliant database of information. 

The company’s signature RYAH vaporizer allows patients to specifically regulate the dose and temperature of their vapor and input information about their medical cannabis use. Then, using artificial intelligence, the device can help doctors give their patients more personalized treatment recommendations.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com 

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ryah Medtech Inc named herein, including the promotion by the Company of Ryah Medtech Inc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

PotBotics says its platform will change how doctors treat patients with...

PotBotics Informatics Specialist Cayla Rosenblum tells Proactive Investors the data aggregation and technology company will soon unveil its new platform called Ryah MD, which works together with PotBotic's vaporizer called Ryah, allowing doctors to make recommendations to patients who use...

on 18/3/19

2 min read